Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $20000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities changed 0.0% year-over-year to $20000.0; the TTM figure through Jun 2026 stood at $20000.0 (changed 0.0% YoY), while the FY2025 annual figure was $20000.0, changed 0.0% from the prior year.
• Other Non-Current Liabilities came in at $20000.0 for Q2 2026 at Adaptive Biotechnologies, roughly flat from $20000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $128.2 million in Q2 2023 to a low of $20000.0 in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $38.9 million, with a median of $20000.0 recorded in 2024.
• Year-over-year, Other Non-Current Liabilities surged 4721.54% in 2022 and sank 99.98% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $125.4 million in 2022, then advanced by 2.24% to $128.2 million in 2023, then slumped by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $20000.0 in Q2 2026, $20000.0 in Q1 2026, and $20000.0 in Q4 2025.